Show Notes
The FDA clearance obtained by startup Ezra for its AI technology marks a significant milestone for the company. Ezra wants to reduce MRI times to 15 minutes. Hear more from Fast Five hosts Danielle Kirsh and Chris Newmarker as they outline what the technology does and its potential to streamline MRI scans.
B. Braun recently launched its DoseTrac Enterprise infusion management software for hospital systems. The technology can connect up to 40,000 different infusion pumps at once. Get the details from Newmarker about how the technology helps hospitals reach significant results and how the mobility of the system increases efficiency.
ABK Biomedical’s FDA investigational device exemption (IDE) approval for tumor-treating microspheres is a significant development in the field of interventional oncology. This milestone enables ABK Biomedical to conduct clinical trials and gather crucial data on the safety and efficacy of their microsphere technology for the treatment of tumors. Kirsh and Newmarker describe the technology and how doctors think it could change oncology treatment.
The recent FDA clearance obtained by Philips and Masimo will have a positive impact on their established partnership. The FDA clearance allows the companies to use SedLine brain function monitoring, Regional Oximetry and CO2 measurements in Philips’ patient monitors, IntelliVue MX750 and MX850. Newmarker explains how the technology combination will help care providers act decisively.
Bayer’s strategic focus on digital health represents a significant shift in their approach to healthcare. By investing in digital health solutions, Bayer aims to leverage technology to improve patient outcomes, enhance healthcare delivery, and drive innovation across the industry. Kirsh and Newmarker share details about the potential play-in from Bayer, including what the company is currently investing in and what it plans to prioritize in its digital health shift.
Check out the show notes at MassDevice.com/podcast.
